NYSE$DCI

Donaldson Company · Q3 2026 earnings

Q3 2026 earnings · · Before market open · Investor relations

Briefing

Donaldson Company reported record third quarter fiscal 2026 sales and earnings with sales up 5.8% and adjusted EPS up 7.1%.

Donaldson achieved net sales of $995.1 million in Q3 2026, up 5.8% year-over-year, with GAAP net earnings of $118.1 million and diluted EPS of $1.00. Adjusted operating margin reached an all-time high of 16.6%, and the company completed the Facet acquisition while narrowing fiscal 2026 guidance to reflect record full-year performance.

  • Q3 sales reached a record $995.1 million, increasing 5.8% driven by volume, pricing, and currency.
  • Adjusted EPS rose 7.1% to $1.06 with adjusted operating margin expanding 30 bps to 16.6%.
  • Mobile and Life Sciences segments delivered strong growth offsetting softness in Industrial.
  • Fiscal 2026 guidance narrowed to organic sales growth of 3-5% and adjusted EPS of $3.94-$4.01 excluding Facet.

Headline financials

Total Revenue

$995M

Previous: $940M+5.9%
EPS (adj)

$1.06

Previous: $1.04+1.9%
Operating Margin

15.6%

Previous: 9.3%+67.7%
Effective Tax Rate

23.7%

Previous: 33.6%-29.5%
EBITDA Margin

18.6%

No prior period
Gross Margin

33.5%

Previous: 34.2%-2.0%
Adjusted Operating Margin

16.6%

Previous: 16.3%+1.8%
Capital Expenditures

-$52.5M

Previous: -$58.6M+10.4%
Free Cash Flow

$241M

Previous: $192M+25.4%
Net Income

$118M

Previous: $57.8M+104.3%
Operating Income

$155M

Previous: $87.4M+77.7%
Gross Profit

$333M

Previous: $322M+3.6%
Cash & Equivalents

$204M

Previous: $179M+14.3%
Total Assets

$3.09B

Previous: $3B+3.0%

Revenue & EPS history

Donaldson · Revenue · Quarterly

$995M

Q3 2026+5.9%vs Q3 2025
Beat estimate in 11 of 16 quarters(69%)
ActualEstimate

Revenue by segment

Donaldson · $995M total across 3 segments · Q3 2026

  • Mobile Solutions
    $630M
  • Industrial Solutions
    $282M
  • Life Sciences
    $83.5M

Forward guidance

Fiscal 2026 guidance narrowed for record sales, adjusted operating margin and adjusted EPS; Facet expected to add $25-30M sales with $0.03 EPS dilution.

Tailwinds

  • Organic sales growth forecast 3-5%
  • Mobile segment growth 3.5-5.5%
  • Life Sciences growth raised to 9-11%

Headwinds

  • Adjusted operating margin guidance lowered to 15.8-16.2%
  • Industrial sales flat to +2%
  • Aerospace and Defense sales down mid-single digits

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2026

Historical avgQ3 2026

+0.0%

Avg return

Earnings day

-0.2%

Avg return

5 days after

-1.4%

Avg return

30 days after

54%

37 / 68 earnings

Positive

+10.1%

Q4 2018

Best reaction

-11.7%

Q2 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026+4.7%+2.4%
Q2 2026-11.7%-10.9%-19.7%
Q1 2026+7.6%+2.9%+2.7%
Q4 2025+8.5%+5.3%+7.1%
Q3 2025-0.1%+1.7%+3.0%
Q2 2025-2.4%-2.5%-3.1%
Q1 2025-6.0%-6.6%-13.8%
Q4 2024-3.9%-2.3%-0.8%
Q3 2024+3.7%+1.7%-1.2%
Q2 2024+6.7%+8.3%+11.2%
Q1 2024+3.5%+5.3%+11.2%
Q4 2023+4.0%+5.8%-2.5%
Q3 2023-7.7%-8.9%-2.5%
Q2 2023+4.9%+4.5%+3.3%
Q1 2023+3.1%+0.7%-0.5%
Q4 2022-2.3%-3.9%-7.4%
Q3 2022+2.6%+1.9%-7.1%
Q2 2022+0.2%-7.5%+0.2%
Q1 2022+0.9%+2.2%+5.0%
Q4 2021-7.5%-9.5%-12.8%
Q3 2021+2.4%+0.5%+2.8%
Q2 2021-4.9%-4.4%-4.9%
Q1 2021+3.0%+3.0%+5.2%
Q4 2020-7.8%-10.3%-7.0%
Q3 2020+3.5%+7.2%-3.6%
Q2 2020-4.9%-4.1%-25.9%
Q1 2020-2.8%+0.7%+5.1%
Q4 2019+7.4%+8.7%+8.2%
Q3 2019+0.7%+1.2%+4.0%
Q2 2019-5.9%-4.6%+1.9%
Q1 2019-9.3%-13.7%-26.1%
Q4 2018+10.1%+13.1%+13.6%
Q3 2018-2.9%-1.2%-5.2%
Q2 2018-5.7%-3.1%-4.7%
Q1 2018-0.2%-0.7%+0.9%
Q4 2017-6.7%-5.1%-0.5%
Q3 2017-2.6%-5.8%-5.0%
Q2 2017+5.1%+5.0%+6.0%
Q1 2017+6.8%+8.6%+3.7%
Q4 2016-1.9%-2.8%-2.1%
Q3 2016+8.6%+9.4%+3.5%
Q2 2016+7.5%
Q1 2016+3.1%
Q4 2015-1.6%
Q3 2015+2.2%
Q2 2015-2.0%
Q1 2015-7.6%
Q4 2014+3.6%
Q3 2014-7.0%
Q2 2014-2.7%
Q1 2014+0.0%
Q4 2013-3.5%
Q3 2013+1.8%
Q2 2013-2.8%
Q1 2013+5.7%
Q4 2012+1.4%
Q3 2012+6.0%
Q2 2012-3.5%
Q1 2012-2.8%
Q4 2009+2.4%
Q4 2011+2.4%
Q4 2010+2.4%
Q3 2011-2.9%
Q3 2010-2.9%
Q2 2010+1.2%
Q2 2011+1.2%
Q1 2010+0.0%
Q1 2011+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro